Clinical Trial Update: Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen [NA]

View source ↗

Summary

This clinical-trial update reports on simplified regimens for HIV patients in ACTG 388 or patients who responded to an initial potent combination regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED